Search Results

There are 35952 results for: content related to: Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma

  1. You have free access to this content
    Adenoviral vector–mediated gene transfer of IL-13Rα2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers

    International Journal of Cancer

    Volume 116, Issue 1, 10 August 2005, Pages: 1–8, Makoto Saito, Takashi Murata, Ken Watanabe, Koji Kawakami, Motoyoshi Suzuki, Takehiko Koji, Raj K. Puri, Kaio Kitazato and Nobuyuki Kobayashi

    Version of Record online : 8 MAR 2005, DOI: 10.1002/ijc.20995

  2. You have free access to this content
    IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma

    International Journal of Cancer

    Volume 124, Issue 6, 15 March 2009, Pages: 1440–1448, Mitomu Kioi, Takeshi Shimamura, Hideyuki Nakashima, Makoto Hirota, Iwai Tohnai, Syed R. Husain and Raj K. Puri

    Version of Record online : 22 OCT 2008, DOI: 10.1002/ijc.24067

  3. You have full text access to this OnlineOpen article
    Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1060–1068, Yi Liu-Chittenden, Meenu Jain, Parag Kumar, Dhaval Patel, Rachel Aufforth, Vladimir Neychev, Samira Sadowski, Sudheer K. Gara, Bharat H. Joshi, Candice Cottle-Delisle, Roxanne Merkel, Lily Yang, Markku Miettinen, Raj K. Puri and Electron Kebebew

    Version of Record online : 13 MAR 2015, DOI: 10.1002/cam4.449

  4. You have free access to this content
    Analysis of interleukin-13 receptor α2 expression in human pediatric brain tumors

    Cancer

    Volume 101, Issue 5, 1 September 2004, Pages: 1036–1042, Mariko Kawakami, Koji Kawakami, Satoru Takahashi, Masato Abe and Raj K. Puri

    Version of Record online : 22 JUL 2004, DOI: 10.1002/cncr.20470

  5. You have free access to this content
    Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin

    International Journal of Cancer

    Volume 114, Issue 6, 10 May 2005, Pages: 870–878, Oscar Gonzalez-Moreno, Alfonso Calvo, Bharat H. Joshi, Ibane Abasolo, Pamela Leland, Zhou Wang, Luis Montuenga, Raj K. Puri and Jeffrey E. Green

    Version of Record online : 17 DEC 2004, DOI: 10.1002/ijc.20789

  6. You have free access to this content
    IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer

    International Journal of Cancer

    Volume 131, Issue 2, 15 July 2012, Pages: 344–356, Toshio Fujisawa, Bharat H. Joshi and Raj K. Puri

    Version of Record online : 16 SEP 2011, DOI: 10.1002/ijc.26366

  7. You have free access to this content
    Interleukin-13 receptor α2 chain

    Cancer

    Volume 107, Issue 6, 15 September 2006, Pages: 1407–1418, Mitomu Kioi, Mariko Kawakami, Takeshi Shimamura, Syed R. Husain and Raj K. Puri

    Version of Record online : 10 AUG 2006, DOI: 10.1002/cncr.22134

  8. You have full text access to this OnlineOpen article
    Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1615–1628, Bharat H. Joshi, Pamela Leland, Samir Lababidi, Frederick Varrichio and Raj K. Puri

    Version of Record online : 10 SEP 2014, DOI: 10.1002/cam4.330

  9. Differential expression of the α2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.

    The Prostate

    Volume 70, Issue 9, 15 June 2010, Pages: 993–1001, Hui He, Jianchun Xu, Peter S. Nelson, Fray F. Marshall, Leland W.K. Chung, Haiyen E. Zhau, Dalin He and Ruoxiang Wang

    Version of Record online : 17 FEB 2010, DOI: 10.1002/pros.21133

  10. You have free access to this content
    Expression and structure of interleukin 4 receptors in primary meningeal tumors

    Cancer

    Volume 103, Issue 10, 15 May 2005, Pages: 2132–2142, Sachin Puri, Bharat H. Joshi, Chitra Sarkar, Ashok Kumar Mahapatra, Ejaz Hussain and Subrata Sinha

    Version of Record online : 13 APR 2005, DOI: 10.1002/cncr.21008

  11. You have free access to this content
    Engineering Toxin-Resistant Therapeutic Stem Cells to Treat Brain Tumors

    STEM CELLS

    Volume 33, Issue 2, February 2015, Pages: 589–600, Daniel W. Stuckey, Shawn D. Hingtgen, Nihal Karakas, Benjamin E. Rich and Khalid Shah

    Version of Record online : 22 JAN 2015, DOI: 10.1002/stem.1874

  12. You have free access to this content
    IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function

    European Journal of Immunology

    Volume 44, Issue 3, March 2014, Pages: 842–855, Mermagya Dhakal, John C. Hardaway, Fatma Betul Guloglu, Mindy M. Miller, Christine M. Hoeman, Adam A. Zaghouani, Xiaoxiao Wan, Linda M. Rowland, Jason A. Cascio, Michael P. Sherman and Habib Zaghouani

    Version of Record online : 13 JAN 2014, DOI: 10.1002/eji.201343755

  13. You have free access to this content
    Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice

    International Journal of Cancer

    Volume 118, Issue 10, 15 May 2006, Pages: 2594–2601, Edward Rustamzadeh, Walter A. Hall, Deborah A. Todhunter, Walter C. Low, Haiying Liu, Angela Panoskaltsis-Mortari and Daniel A. Vallera

    Version of Record online : 15 DEC 2005, DOI: 10.1002/ijc.21647

  14. Mapping mouse IL-13 binding regions using structure modeling, molecular docking, and high-density peptide microarray analysis

    Proteins: Structure, Function, and Bioinformatics

    Volume 79, Issue 1, January 2011, Pages: 282–293, Satish K. Madala, Michael A. Dolan, Deepak Sharma, Thirumalai R. Ramalingam, Mark S. Wilson, Margaret M. Mentink-Kane, Daniel C. Masison and Thomas A. Wynn

    Version of Record online : 9 NOV 2010, DOI: 10.1002/prot.22881

  15. A novel and sensitive ELISA reveals that the soluble form of IL-13R-α2 is not expressed in plasma of healthy or asthmatic subjects

    Clinical & Experimental Allergy

    Volume 38, Issue 4, April 2008, Pages: 594–601, M. O'Toole, H. Legault, R. Ramsey, T. A. Wynn and M. T. Kasaian

    Version of Record online : 25 FEB 2008, DOI: 10.1111/j.1365-2222.2007.02921.x

  16. You have free access to this content
    Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine

    International Journal of Cancer

    Volume 128, Issue 5, 1 March 2011, Pages: 1221–1231, Toshio Fujisawa, Hideyuki Nakashima, Atsushi Nakajima, Bharat H. Joshi and Raj K. Puri

    Version of Record online : 5 MAY 2010, DOI: 10.1002/ijc.25437

  17. You have free access to this content
    Interleukin-13 receptor as a unique target for anti-glioblastoma therapy

    International Journal of Cancer

    Volume 92, Issue 2, 15 April 2001, Pages: 168–175, Syed R. Husain, Bharat H. Joshi and Raj K. Puri

    Version of Record online : 13 FEB 2001, DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N

  18. Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation

    Journal of Molecular Recognition

    Volume 25, Issue 3, March 2012, Pages: 184–191, Eilyn R. Lacy

    Version of Record online : 28 FEB 2012, DOI: 10.1002/jmr.2150

  19. You have free access to this content
    Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13

    International Journal of Cancer

    Volume 76, Issue 4, 18 May 1998, Pages: 547–551, Waldemar Debinski, Denise M. Gibo and Raj K. Puri

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980518)76:4<547::AID-IJC17>3.0.CO;2-4

  20. Interleukin-13 in asthma pathogenesis

    Immunological Reviews

    Volume 202, Issue 1, December 2004, Pages: 175–190, Marsha Wills-Karp

    Version of Record online : 11 NOV 2004, DOI: 10.1111/j.0105-2896.2004.00215.x